# BIODELIVERY SCIENCES INTL IN (BDSI)

> Institutional ownership reported to the SEC as of Q1 2022, from Form 13F filings. Source: https://holderbook.com/stocks/BDSI/

- Reporting holders: 4
- Reported value: $64.0K
- Held through calls: 53.1%
- Held through puts: 4.7%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $37.0K | 0 | 0.0% | 14 |
| [Close Asset Management Ltd](https://holderbook.com/funds/1718570-close-asset-management-ltd/) | $23.0K | 7,500 | 0.0% | 14 |
| [Founders Capital Management](https://holderbook.com/funds/1704300-founders-capital-management/) | $3.0K | 1,000 | 0.0% | 9 |
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $1.0K | 250 | 0.0% | 11 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2022 | 4 | $64.0K |
| Q4 2021 | 157 | $190.5M |
| Q3 2021 | 152 | $227.2M |
| Q2 2021 | 145 | $217.7M |
| Q1 2021 | 149 | $252.9M |
| Q4 2020 | 140 | $287.1M |
| Q3 2020 | 147 | $253.8M |
| Q2 2020 | 158 | $309.7M |
| Q1 2020 | 151 | $263.4M |
| Q4 2019 | 159 | $446.8M |
| Q3 2019 | 120 | $256.8M |
| Q2 2019 | 113 | $289.6M |